Elanco Animal Health (ELAN) Construction in Progress (2024)

Elanco Animal Health's (ELAN) quarterly Construction in Progress came in at $42.0 million in Q4 2024.

Elanco Animal Health (ELAN) Construction in Progress (2024) Analysis & Trends

Elanco Animal Health has disclosed Construction in Progress across 1 years of filings, most recently posting $42.0 million for Q4 2024.

  • Construction in Progress for Q4 2024 came in at $42.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $42.0 million (changed N/A YoY), and the FY2024 annual result was $42.0 million, changed N/A from the prior year.
  • Construction in Progress came in at $42.0 million for Q4 2024 at Elanco Animal Health.
  • In the past five years, Construction in Progress ranged from a high of $42.0 million in Q4 2024 to a low of $42.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 42.00 Mn